Article
Characterisation of IL-23 receptor antagonists and disease relevant mutants using fluorescent probes.
Nature communications - 19 May 2023
Lay Charles S, Isidro-Llobet Albert, Kilpatrick Laura E, Craggs Peter D, Hill Stephen J
Abstract excerpt
Association of single nucleotide polymorphisms in the IL-23 receptor with several auto-inflammatory diseases, led to the heterodimeric receptor and its cytokine-ligand IL-23, becoming important drug targets. Successful antibody-based therapies directed against the cytokine have been licenced and a class of small peptide antagonists of the receptor have entered clinical trials. These peptide antagonists may offer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
